RLAY

RELAY THERAPEUTICS INC

RLAY·75943R102·US·Common Stock·Healthcare - Biotechnology-13D/G

RLAY (RELAY THERAPEUTICS INC) is held by 132 institutional investors as of Q1 2026. Largest holders: SB INVESTMENT ADVISERS (UK) LTD ($277.7M), BlackRock, Inc. ($129.1M), VANGUARD CAPITAL MANAGEMENT LLC ($73.5M). Net institutional sentiment: Bullish.

132
Holders
(12 Elite)
$1.1B
Total Value
70% (132)
Consensus
92 buying - 40 selling
13F: Insider & Congress:
RLAYSmart Money Verdict
View all
Held by 132 funds
12 elite
Who's Trading
InsiderBABergstrom Donald ASell $1.6MJun 22, 2026
InsiderCTCatinazzo ThomasSell $1.0MJun 22, 2026
InsiderCTCatinazzo ThomasSell $956KJun 22, 2026
InsiderCTCatinazzo ThomasSell $301KJun 22, 2026
InsiderCTCatinazzo ThomasSell $875KJun 22, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.0%May 15, 2026
InsiderBABergstrom Donald ASell $22KApr 28, 2026
InsiderRPRahmer PeterSell $11KApr 28, 2026
InsiderCTCatinazzo ThomasSell $14KApr 28, 2026
ActivistPAPerceptive Advisors LLC10.0%Apr 13, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
27.9M$277.7M3.6%-49.97%
0
Decreased
13M(-1.9%)$129.1M0.0%+378.47%
0
New
7.4M$73.5M0.0%+103.05%
41
Decreased
6.2M(-3.0%)$62M0.0%+120.70%
0
Increased
3.7M(+2178.0%)$36.8M0.0%+108.88%
47
Increased
3.5M(+3.0%)$34.9M0.0%+6.04%
30
Increased
3M(+44.7%)$30.2M0.0%+163.44%
39
Increased
2.9M(+18.6%)$29.2M0.0%+112.66%
34
Increased
2.6M(+418.0%)$25.8M0.0%+109.20%
46
Increased
2.5M(+36.7%)$25.3M0.0%+250.77%
37
Increased
1.9M(+86.2%)$19.3M0.0%+209.02%
44
Increased
1.9M(+17.0%)$19.2M0.0%+69.73%
33
New
1.9M$18.5M0.0%+103.05%
39
Increased
1.7M(+47.1%)$16.7M0.0%+7.24%
39
Decreased
1.6M(-0.3%)$15.6M0.4%+33.87%
0
Decreased
1.4M(-29.1%)$14.2M0.0%+251.90%
0
Decreased
1.4M(-12.3%)$13.6M0.0%+175.07%
0
Increased
1.3M(+10.9%)$12.8M0.0%+348.00%
31
Unchanged
1.2M$11.5M0.1%+47.48%
0
Decreased
1.1M(-2.2%)$11.1M0.0%-2.29%
0

Showing 1-20 of 141

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used